Posted: 1st August 2017
Between 15th and 18th, August 2017 Abingdon Health will be attending the Next Generation Dx Summit in Washington DC to showcase its current and next-generation rapid diagnostics technology
Abingdon Health has significant experience in the development and manufacture of qualitative and quantitative lateral flow assays across a range of industry sectors. To enable us to continue to deliver the best possible lateral flow and reader technology solutions to our customers we remain committed to investing in the development of innovative rapid diagnostics technology.
During the Next Generation Dx Summit Abingdon Health will be showcasing its next generation biosensor. In partnership with Cambridge Display Technology, a Sumitomo Chemical Group Company, Abingdon Health is developing a multiplexed rapid diagnostics biosensor to meet the market need for a simple to use, rapid, cost-effective, portable systems.
On hand at Next Generation Dx Summit will be Lisa Mansell and Hayley Clarke to discuss Abingdon Health’s products and services.
Lisa Mansell (Business Development Manager)
Lisa has many years of experience working with organisations from the healthcare, veterinary and plant health sectors that require qualitative or quantitative rapid assay development and/or manufacture.
Hayley Clarke (Key Account Manager)
Having worked with lateral flow assay development projects for many years, Hayley is well placed to discuss the flexible nature of LFDs and how they can be applied to detect many different markers in a variety of different matrices.
If you would like to arrange a meeting with Lisa or Hayley at Next Generation Dx Summit please contact them on +44 (0) 1904 406080 or email@example.com.
If you are not attending Next Generation Dx Summit but would like to discuss opportunities with either Lisa or Hayley please contact them using the details above.
© Abingdon Health 2017